Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Michigan Rogel Cancer Center
Eastern Cooperative Oncology Group
R-Pharm
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
University of California, San Francisco
Guangxi Medical University
Incyte Corporation
Insel Gruppe AG, University Hospital Bern
Sanford Health
Centre Antoine Lacassagne
Groupe Oncologie Radiotherapie Tete et Cou
Merck Sharp & Dohme LLC
GERCOR - Multidisciplinary Oncology Cooperative Group
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Merck Sharp & Dohme LLC
Sun Yat-sen University
First Affiliated Hospital of Fujian Medical University
West China Hospital
University of Chicago
Thomas Jefferson University
University of Chicago
Akeso
UNICANCER
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
National Cancer Institute (NCI)
BeiGene
The Netherlands Cancer Institute
AstraZeneca
Hospital of Stomatology, Wuhan University
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
EpicentRx, Inc.
Institute of Oncology Ljubljana
University of Chicago
University of Birmingham
University of Pittsburgh
M.D. Anderson Cancer Center
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Icahn School of Medicine at Mount Sinai
University Medical Center Groningen
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Austrian South Oncology Group
Stanford University
University of Chicago